# Tae‐You Kim

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/tae-you-kim/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,470 |
| Field | Hepatocellular Carcinoma Treatment and Prognosis |
| h-index | 47 |
| i10-index | 126 |
| Last Known Institution | Seoul National University of Science and Technology |
| OpenAlex ID | https://openalex.org/A5088893123 |
| ORCID iD | https://orcid.org/0000-0002-9986-2684 |
| Works | 190 |

## Researcher papers

- [Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial](https://scholariq.org/papers/ramucirumab-plus-paclitaxel-versus-placebo-plus-paclitaxel-in-patients-with/)
- [Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced Malignancies](https://scholariq.org/papers/phase-i-and-pharmacokinetic-study-of-genexol-pm-a-cremophor-free-polymeric/)

## Researcher topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Genetic factors in colorectal cancer](https://scholariq.org/topics/genetic-factors-in-colorectal-cancer/)

## Researcher university

- [Seoul National University of Science and Technology](https://scholariq.org/institutions/seoul-national-university-of-science-and-technology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.